Purpose of ganoderan in preparation of health food for regulating flora in intestinal tract
A technology for regulating intestinal flora and Ganoderma lucidum polysaccharides, applied in the biological field, can solve problems such as no metagenomic research reports on Ganoderma lucidum polysaccharides
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] The Ganoderma lucidum polysaccharide of the present invention is prepared by the following preparation method: After crushing the Ganoderma lucidum, add water according to the ratio of Ganoderma lucidum: water = 1g: 5mL, heat and stir at 75°C for 3 hours, and filter the obtained filter residue according to the above-mentioned material-liquid ratio and temperature Continue to extract twice with time, combine three extractions, concentrate under reduced pressure and centrifuge to obtain a clarified concentrate, add 9 times the volume of 95% ethanol to the clarified concentrate according to the volume ratio of the clarified concentrate: 95% ethanol=1:9 After mixing, let stand overnight at 4°C to precipitate, centrifuge to collect the precipitate, and vacuum freeze-dry to obtain Ganoderma lucidum polysaccharide.
Embodiment 2
[0047] The applicant of the present invention has carried out a pharmacological experiment using the Ganoderma lucidum polysaccharide prepared in the above-mentioned Example 1,
[0048] The experimental results are as follows:
[0049] 1. Experimental materials
[0050] 1.1. Experimental Instruments
[0051] Thermo full-wavelength microplate reader: Thermo Fisher Scientific China, 1510;
[0052] JA1203N analytical balance: product of Shanghai Precision Instrument Co., Ltd.;
[0053] Electronic balance: Changshu Shuangjie Testing Instrument Factory, T1000.
[0054] 1.2. Experimental reagents
[0055] Glucose determination kit: Shanghai Rongsheng Biopharmaceutical Co., Ltd., 20131207147;
[0056] Total cholesterol assay kit: Shanghai Rongsheng Biopharmaceutical Co., Ltd., 20131105146;
[0057] Triglyceride determination kit: Shanghai Rongsheng Biopharmaceutical Co., Ltd., 20131105121;
[0058] Low-density lipoprotein assay kit: Shanghai Rongsheng Biopharmaceutical Co., Lt...
Embodiment 3
[0104] The fresh feces of the mice in the 12th week of the mouse experiment in Application Example 1 were collected, and the intestinal flora among different groups were analyzed for differences. figure 1 And B, positive drug group in table 6, C, normal group, D, Ganoderma polysaccharide group 1, E, Ganoderma polysaccharide group 2, F, Ganoderma polysaccharide group 3, M, model group (grouping is the same as table 2 in embodiment 2) .
[0105] This research is most concerned about whether the bacteria with differences between the M model group and the C normal group can be adjusted after treatment, and the figure 1 . figure 1 The OTUs selected in are the OTUs with differences between the C normal group and the M model group (their effectsize>1.96), and then these OTUs are also tested between other groups and the M model group, and the obtained effectsize draws the above heat map . From figure 1 It can be easily seen that the effect of the positive drug is very significant,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com